Sinocare

Sinocare Inc., established in August 2002, is a prominent player in the Medical Devices & Equipment and Manufacturing sectors, specializing in bio-sensor technology research, development, manufacturing, and marketing of Point-of-Care Testing (POCT) products. The company's strategic focus on intensive R&D and technological innovation drives its mission to deliver significant health benefits. Its flagship Blood Glucose Monitoring System (BGMS) is recognized for accuracy, simplicity, and affordability, serving a broad consumer base.

Operating with 1,000-5,000 employees, Sinocare generates substantial revenue, reported at $289.6M. While its primary location count is one, the company's reach extends globally through exports to numerous countries. Sinocare is committed to advancing its position as a "portable laboratory" through continuous innovation in POCT products. This dedication to technological advancement is supported by its team, and interested parties can learn more by Meet Sinocare's team. The company adheres to core values of equality, honesty, innovation, and excellence in its operations.

Sinocare aims to enhance the quality of life for patients with diabetes and other chronic diseases, particularly within China, by providing high-quality products and services. This initiative also seeks to alleviate the burden on the social healthcare system. The company's product portfolio, including advanced biomedical engineering and monitoring systems, reflects its commitment to addressing critical health needs with cutting-edge, accessible technology.